Precision Medicine News and Research

RSS

Evaluating how bacterial therapeutics may synergize with existing anti-cancer therapies

It may come as a surprise, but bacteria love to grow inside tumors. It's the environment-;tumors are typically acidic, have low amounts of oxygen, and are filled with dead cells, which all facilitate bacterial growth.

6 Mar 2023

New imaging method could help make better decisions on personalized cancer treatment

Decisions on cancer treatment could become better tailored to individual patients with the adoption of a new imaging method being developed by University of Michigan researchers that maps the chemical makeup of a patient’s tumor.

1 Mar 2023

Chemotherapy affects the cellular landscape of tumor microenvironment in pancreatic cancer

Chemotherapy affects the ability of a patient's immune system to attack pancreatic tumors, a new study shows.

1 Mar 2023

Using AI for early diagnosis of cardiovascular disease

Researchers may be able to predict cardiovascular disease – such as arterial fibrillation and heart failure – in patients by using artificial intelligence (AI) to examine the genes in their DNA, according to a new Rutgers study.

27 Feb 2023

New ensemble learning model could predict dementia in older drivers with excellent accuracy

Using ensemble learning techniques and longitudinal data from a large naturalistic driving study, researchers at Columbia University's Mailman School of Public Health, Fu Foundation School of Engineering and Applied Science, and Vagelos College of Physicians and Surgeons have developed a novel, interpretable and highly accurate algorithm for predicting mild cognitive impairment and dementia in older drivers.

23 Feb 2023

New machine-learning statistical model may be able to predict COVID-19 resistance

Researchers from Johns Hopkins Medicine and The Johns Hopkins University have created and preliminarily tested what they believe may be one of the first models for predicting who has the highest probability of being resistant to COVID-19 in spite of exposure to SARS-CoV-2, the virus that causes it.

22 Feb 2023

Challenges associated with prescribing exercise to diabetic patients taking metformin

In a recent study published in the Sports Medicine and Health Science journal, researchers assessed the impact of exercise precision medicine on type 2 diabetes.

21 Feb 2023

Genes encoding T cell receptors vary greatly between persons and populations, study reveals

Researchers from Karolinska Institutet have discovered that the genes encoding our T cell receptors vary greatly between persons and populations, which may explain why we respond differently to for example infections.

16 Feb 2023

A call to action proposed for health providers to ensure widest distribution, easy availability of naloxone

In 2021, 100,306 Americans died from drug overdoses – a 28.5 percent increase from the prior year – with 75,673 attributed to opioids.

16 Feb 2023

Tapping mothers’ and babies’ medical records to better predict prematurity complications

By sifting through electronic health records of moms and babies using a machine-learning algorithm, scientists can predict how at-risk newborns will fare in their first two months of life.

16 Feb 2023

Study provides insight into the immune microenvironment around Hodgkin lymphoma tumors

The most comprehensive study to date of the blood cancer, Hodgkin lymphoma, has provided fascinating insights into what tumour cells must do to survive. Researchers from the Wellcome Sanger Institute found that cancer cells use signals to attract certain types of immune cell and instruct them not to attack.

16 Feb 2023

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meetin

Complete Genomics Inc., a global life science tools leader and subsidiary of MGI Tech Co., Ltd. (“MGI”), today launched new revolutionary products and prices at Advances in Genome Biology and Technology (AGBT) General Meeting.

From MGI 14 Feb 2023

Five teams awarded funding from the Starr Cancer Consortium to advance cancer research

Five teams led by Weill Cornell Medicine scientists have been awarded funding from the Starr Cancer Consortium in its 16th annual grant competition.

10 Feb 2023

Complete Genomics drops genome sequencing price to sub $100 at AGBT general meeting

From Complete Genomics 9 Feb 2023

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting

From Complete Genomics 9 Feb 2023

Four teams supported by SU2C focus on increasing diversity in early phase cancer clinical trials

Stand Up To Cancer today announced four teams focused on increasing diversity in early phase cancer clinical trials.

8 Feb 2023

CardioGen automated interpretation system for diagnosis of monogenic cardiovascular diseases

Monogenic cardiovascular disease is a genetic disease in which cardiovascular damage is the only or main phenotype. The total current number of patients worldwide exceeds 10 million.

8 Feb 2023

Novel nuclear medicine imaging protocol cuts costs and radiation exposure for Alzheimer's patients

A novel nuclear medicine imaging protocol can take the place of two separate imaging scans for the evaluation of brain changes linked to cognitive impairment, cutting costs and radiation exposure for patients as well as providing them greater comfort.

8 Feb 2023

Researchers highlight the dysregulation of hepatokines in people with NAFLD

Non-alcoholic fatty liver disease (NAFLD) is an important risk factor for type 2 diabetes and cardiovascular diseases.

7 Feb 2023

Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection

Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy® for applications in early disease detection and precision medicine, today announced the publication of a peer-reviewed study in the Journal of Clinical and Translational Hepatology, “Breath Biopsy to identify exhaled volatile organic compounds as biomarkers for liver cirrhosis detection”.

From Owlstone Medical Ltd 7 Feb 2023

Precision Medicine News and Research

Evaluating how bacterial therapeutics may synergize with existing anti-cancer therapies

New imaging method could help make better decisions on personalized cancer treatment

Chemotherapy affects the cellular landscape of tumor microenvironment in pancreatic cancer

Using AI for early diagnosis of cardiovascular disease

New ensemble learning model could predict dementia in older drivers with excellent accuracy

New machine-learning statistical model may be able to predict COVID-19 resistance

Challenges associated with prescribing exercise to diabetic patients taking metformin

Genes encoding T cell receptors vary greatly between persons and populations, study reveals

A call to action proposed for health providers to ensure widest distribution, easy availability of naloxone

Tapping mothers’ and babies’ medical records to better predict prematurity complications

Study provides insight into the immune microenvironment around Hodgkin lymphoma tumors

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meetin

Five teams awarded funding from the Starr Cancer Consortium to advance cancer research

Complete Genomics drops genome sequencing price to sub $100 at AGBT general meeting

Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting

Four teams supported by SU2C focus on increasing diversity in early phase cancer clinical trials

CardioGen automated interpretation system for diagnosis of monogenic cardiovascular diseases

Novel nuclear medicine imaging protocol cuts costs and radiation exposure for Alzheimer's patients

Researchers highlight the dysregulation of hepatokines in people with NAFLD

Owlstone Medical Publishes Data on the Use of Exhaled Volatile Organic Compounds as Biomarkers for Liver Disease Detection

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News